OraSure Technologies Inc (OSUR)

NASDAQ
11.790
+0.120(+1.03%)
After Hours
11.790
0.000(0.00%)
- Real-time Data
  • Volume:
    603,133
  • Bid/Ask:
    11.380/11.980
  • Day's Range:
    11.585 - 11.940

OSUR Overview

Prev. Close
11.67
Day's Range
11.585-11.94
Revenue
198.7M
Open
11.6
52 wk Range
8.58-19.75
EPS
-0.07
Volume
603,133
Market Cap
848.41M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
902,981
P/E Ratio
-
Beta
-0.29
1-Year Change
-35.04%
Shares Outstanding
71,960,048
Next Earnings Date
Aug 03, 2021
What is your sentiment on OraSure Technologies Inc?
or
Market is currently closed. Voting is open during market hours.

OraSure Technologies Inc News

OraSure Technologies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Sell
SummaryNeutralNeutralStrong BuyStrong BuyNeutral

OraSure Technologies Inc Company Profile

OraSure Technologies Inc Company Profile

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, Diagnostics and Molecular Solutions. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company’s principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company offers ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbime, and animal genetics markets. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

Read More
  • Pump tomorrow
    0
    • nice pizdej
      0
  • It will be back to 20’s.
    0
    • If not in Nov, Dec.
      0
    • Roberto Costa you were right
      0
    • what is happening to this
      0
  • Big news = big movement tomorrow
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.